"Neurofibroma, Plexiform" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. (From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131(5):678-82)
| Descriptor ID |
D018318
|
| MeSH Number(s) |
C04.557.580.600.580.585 C10.551.775.500.750.500 C10.668.829.725.500.600.500
|
| Concept/Terms |
Neurofibroma, Plexiform- Neurofibroma, Plexiform
- Neurofibromas, Plexiform
- Plexiform Neurofibroma
- Plexiform Neurofibromas
- Tumor Royale
- Pachydermatocele
- Pachydermatoceles
- Elephantiasis Neuromatosis
- Elephantiasis Neuromatoses
- Neuromas, Plexiform
- Neuroma, Plexiform
- Plexiform Neuroma
- Plexiform Neuromas
|
Below are MeSH descriptors whose meaning is more general than "Neurofibroma, Plexiform".
Below are MeSH descriptors whose meaning is more specific than "Neurofibroma, Plexiform".
This graph shows the total number of publications written about "Neurofibroma, Plexiform" by people in this website by year, and whether "Neurofibroma, Plexiform" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurofibroma, Plexiform" by people in Profiles.
-
Gross AM, Wolters PL, Dombi E, Baldwin A, Whitcomb P, Fisher MJ, Weiss B, Kim A, Bornhorst M, Shah AC, Martin S, Roderick MC, Pichard DC, Carbonell A, Paul SM, Therrien J, Kapustina O, Heisey K, Clapp DW, Zhang C, Peer CJ, Figg WD, Smith M, Glod J, Blakeley JO, Steinberg SM, Venzon DJ, Doyle LA, Widemann BC. Selumetinib in Children with Inoperable Plexiform Neurofibromas. N Engl J Med. 2020 04 09; 382(15):1430-1442.
-
Pemov A, Hansen NF, Sindiri S, Patidar R, Higham CS, Dombi E, Miettinen MM, Fetsch P, Brems H, Chandrasekharappa SC, Jones K, Zhu B, Wei JS, Mullikin JC, Wallace MR, Khan J, Legius E, Widemann BC, Stewart DR. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro Oncol. 2019 08 05; 21(8):981-992.
-
Pulido JS, Heier JS, Marmorstein AD. Selumetinib in Plexiform Neurofibromas. N Engl J Med. 2017 03 23; 376(12):1195.
-
Sereni CP, Rodgers SK. SRU Cases of the Day: Plexiform Neurofibroma. Ultrasound Q. 2016 Sep; 32(3):312-3.
-
Michal M, Fanburg-Smith JC, Mentzel T, Kutzner H, Requena L, Zamecnik M, Miettinen M. Dendritic cell neurofibroma with pseudorosettes: a report of 18 cases of a distinct and hitherto unrecognized neurofibroma variant. Am J Surg Pathol. 2001 May; 25(5):587-94.